788 related articles for article (PubMed ID: 21196707)
1. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W; Schwarz HP
Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
[TBL] [Abstract][Full Text] [Related]
2. Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia.
Claahsen-van der Grinten HL; Noordam K; Borm GF; Otten BJ
J Clin Endocrinol Metab; 2006 Apr; 91(4):1205-9. PubMed ID: 16464952
[TBL] [Abstract][Full Text] [Related]
3. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W; Schmidt H; Schwarz HP
Horm Res Paediatr; 2011; 75(1):32-7. PubMed ID: 20714115
[TBL] [Abstract][Full Text] [Related]
4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
5. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM; Addo OY; Kyllo J; Gonzalez-Bolanos MT; Ltief AM; Pittock S; Himes JH; Miller BS; Sarafoglou K
J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
[TBL] [Abstract][Full Text] [Related]
6. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
[TBL] [Abstract][Full Text] [Related]
7. [Growth and adult height in patients with congenital adrenal hyperplasia].
Kolousková S; Zemková D; Snajderová M; Lebl J
Cas Lek Cesk; 1995 Nov; 134(21):689-91. PubMed ID: 8556761
[TBL] [Abstract][Full Text] [Related]
8. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
Hargitai G; Sólyom J; Battelino T; Lebl J; Pribilincová Z; Hauspie R; Kovács J; Waldhauser F; Frisch H;
Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369
[TBL] [Abstract][Full Text] [Related]
9. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP; Winter A; Stolecke H
Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958
[TBL] [Abstract][Full Text] [Related]
11. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
Bretones P; Riche B; Pichot E; David M; Roy P; Tardy V; Kassai B; Gaillard S; Bernoux D; Morel Y; Chatelain P; Nicolino M; Cornu C;
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1379-1388. PubMed ID: 27852974
[TBL] [Abstract][Full Text] [Related]
12. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I; Kanaka-Gantenbein Ch; Voutetakis A; Maniati-Christidi M; Dacou-Voutetakis C
Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
[TBL] [Abstract][Full Text] [Related]
13. Growth in disorders of adrenal hyperfunction.
Savage MO; Scommegna S; Carroll PV; Ho JT; Monson JP; Besser GM; Grossman AB
Horm Res; 2002; 58 Suppl 1():39-43. PubMed ID: 12373013
[TBL] [Abstract][Full Text] [Related]
14. Growth and development in children with classic congenital adrenal hyperplasia.
Bonfig W
Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):39-42. PubMed ID: 27898585
[TBL] [Abstract][Full Text] [Related]
15. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
16. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
Aycan Z; Ocal G; Berberoglu M; Cetinkaya E; Adiyaman P; Evliyaoglu O
J Pediatr Endocrinol Metab; 2006 Mar; 19(3):245-51. PubMed ID: 16607925
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L/I172N genotype.
Tankoska M; Anastasovska V; Krstevska-Konstantinova M; Naydenov M; Kocova M
J Pediatr Endocrinol Metab; 2019 May; 32(5):543-547. PubMed ID: 31026224
[TBL] [Abstract][Full Text] [Related]
18. Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH).
Hoyer-Kuhn H; Eckert AJ; Binder G; Bonfig W; Dübbers A; Riedl S; Woelfle J; Dörr HG; Holl RW
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1199-e1204. PubMed ID: 37256841
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Growth in Children With Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency During Adrenarche and Beyond.
Troger T; Sommer G; Lang-Muritano M; Konrad D; Kuhlmann B; Zumsteg U; Flück CE
J Clin Endocrinol Metab; 2022 Jan; 107(2):e487-e499. PubMed ID: 34599587
[TBL] [Abstract][Full Text] [Related]
20. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C; Improda N; Maggioli C; Capalbo D; Roma S; Porzio O; Salerno M; Cappa M
Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]